SEC Form 4 · accession 0001140361-17-036981
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam Havey
Officer — EVP, Business Operations
Period of report
Sep 27, 2017
Accepted (ET)
Sep 29, 2017 · 4:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 27, 2017 | M | 7,885 | $22.03 | A | 33,931 | D | |
| Common StockF1 | Sep 27, 2017 | S | 7,885 | $39.50 | D | 26,046 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F3 | $22.03 | Sep 27, 2017 | M | 7,885 | D | — | Mar 14, 2018 | Common Stock | 7,885 | 0 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
- F2Consists of an option granted under the company's stock incentive plan as amended and restated.
- F3The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.